Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2009-01-14
2011-11-22
Wen, Sharon (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S141100, C424S130100
Reexamination Certificate
active
08062639
ABSTRACT:
The present invention relates to compositions and methods of use thereof for treatment of clinical conditions manifested from and/or exacerbated by a decrease or an inhibition of Na/K ATPase activity. The invention relates to composition comprises monoclonal or polyclonal antibodies to bufalin and/or bufalin sulfate, or vaccination against bufalin and/or bufalin sulfate, which prevents or attenuates inhibition of Na/K ATPase activity thereby attenuating the adverse physiological effects of bufalin and/or bufalin sulfate inhibition. The invention also relates to methods of treating hemorrhagic, septic shock, cardiogenic shock, shock resulting from physical trauma, diabetes, mental depression, bipolar disorder and schizophrenia comprising administering a therapeutically effective amount of an bufalin monoclonal or polyclonal antibody.
REFERENCES:
patent: 2006/0134106 (2006-06-01), Adair
Darlington Daniel Norman
Gann Donald Stuart
LandOfFree
Antibodies to bufalin prevent inhibition of Na/K ATPase and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to bufalin prevent inhibition of Na/K ATPase and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to bufalin prevent inhibition of Na/K ATPase and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4284436